What autoimmune conditions might benefit most from tirzepatide anti-inflammatory effects
However, as treatment progresses and GLP-1 levels rise during refeeding, they may remain elevated, potentially contributing to delayed gastric emptying and lower postprandial glucose levelsfactors that can complicate the refeeding process as the body adjusts to normal intake (126)
The Nuance of Microdosing and Compounded Semaglutide Under Medical Supervision While self-administering two shots a week of any semaglutide is strongly discouraged, the concept of microdosing or splitting a weekly dose into smaller, more frequent injections has been explored by some healthcare providers as a strategy to manage side effects, particularly with compounded semaglutide
Tirzepatide may be considered when insulin resistance is a major factor because it targets both GIP and GLP-1 pathways
excess is excreted in urine, often causing bright yellow coloration, and no upper toxicity level has been observed)